-
Most Popular
![Healthcare Stocks Icon](https://investorplace.com/wp-content/uploads/2022/12/healthcare-150x150.png)
Healthcare Stocks
Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.
![The words "recession proof" written on a pink sticky note. bulletproof stocks](https://investorplace.com/wp-content/uploads/2023/07/shutterstock_2170602547-150x150.jpg)
7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024
These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.
![Interest rate and dividend concept. Businessman with percentage symbol and up arrow, Interest rates continue to increase, return on stocks and mutual funds, long term investment for retirement. Dividend stocks](https://investorplace.com/wp-content/uploads/2024/06/dividend-stocks1600-5-150x150.png)
7 Dependable Dividend Stocks for Long-Term Income
Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.
![medicine research, pharmaceutical background, LJPC stock](https://investorplace.com/wp-content/uploads/2022/03/pharmaceuticals_tnxp_1600-150x150.png)
3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct
These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.
Recent Healthcare Stocks Articles
ABBV Stock: Buy for the Yield, Hold for This Other Reason
"Safe harbor" status and a high, growing dividend yield isn't the only thing that's appealing with ABBV stock.
TTOO Stock Alert: T2 Biosystems Announces Reverse Stock Split
Shares of TTOO stock will begin trading on a 1-for-100 reverse stock split adjusted basis starting tomorrow, Oct. 13.
Why Is Phio Pharma (PHIO) Stock Down 35% Today?
Phio Pharma stock is pulling back on Thursday after shares of PHIO underwent a massive rally on Wednesday with a preclinical trial update.
Why Is Tempest Therapeutics (TPST) Stock Down 35% Today?
Tempest Therapeutics stock is taking a beating on Thursday as shares of TPST retreat from a massive rally yesterday on clinical trial news!
Why Is OpGen (OPGN) Stock Up 540% Today?
OpGen stock is undergoing a massive rally on Thursday following as OPGN investors react to two pieces of news from the company!
PFE Stock Warning: Avoid This Big Pharma Value Trap at All Costs
PFE stock may look like a bargain among healthcare stocks, but despite its low valuation and high yield, further declines are likely.
TPST Stock: 7 Things to Know About Tempest Therapeutics
Are you curious about the recent surge from Tempest Therapeutics? Here's a closer look at this company and at TPST stock.
2 A-Rated Cannabis Stocks Are the ONLY Ones You Should Buy Right Now
Cannabis stocks are losers... except for these two A-rated names. Investors would be wise to get ahead early on these first-tier winners.
Wall Street Warms Up to Tempest as TPST Stock Surges 1,500%
TPST stock is surging higher after the company released new positive data concerning its TPST-1120 drug candidate.
WBA Stock Alert: What to Know as Walgreens Names New CEO
Walgreens stock is a hot topic among WBA traders on Wednesday after the company announced Tim Wentworth as its next CEO.
Why This Household Name Is a Top Pick for Dividend Investors
PG stock has struggled over the past month, but this Dividend King remains a strong choice for long-term steady returns.
UNH Stock Alert: Don’t Buy UnitedHealth Before Oct. 13!
UnitedHealth Group has a stellar earnings track record. However, that record will soon be put to the test, so be careful with UNH stock.
Why Is Ocugen (OCGN) Stock Up 5% Today?
Ocugen stock is rising higher on Tuesday thanks to OCGN investors celebrating news of a new clinical trial for its Covid-19 vaccine.